Articles tagged with: Tragara Pharmaceuticals
Myeloma Experts From University Of Arkansas Answer Questions At The Myeloma Beacon Forums This Week – Dr. Bart Barlogie and Dr. Bijay Nair, myeloma experts from the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences will be answering medical questions posted to the forums at the Myeloma Beacon this week. Readers can post their questions and review answers from other myeloma experts by visiting the Myeloma Beacon Forums.
MMRF Grants Funding To Intellikine and Tragara Pharmaceuticals For Novel Myeloma Treatments – The Multiple Myeloma Research Foundation (MMRF) announced last week that it will award Intellikine and Tragara Pharmaceuticals, two biotech companies based in Southern California, with $1 million each for the development of two new compounds for the treatment of multiple myeloma. Intellikine’s INK128 and Tragara Pharmaceuticals’ TG02 have both shown potential for multiple myeloma in pre-clinical studies. For more information, please see the MMRF press release.
5th Annual “Music Against Myeloma” Fundraiser To Be Held In NYC – On April 22, special musical performances will take place during the 5th annual “Music Against Myeloma” fundraiser to the benefit of the International Myeloma Foundation. The event will take place at BLVD in New York City from 7 to 10 p.m. Advance tickets are $40. Please see the Music Against Myeloma Web site for additional information and to purchase tickets.
For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.